文献速递头颈神经PETCTMR

18F-FDG PET、CT与MRI在头颈部恶性肿瘤神经周围播散中的诊断与预后价值

Diagnostic and prognostic value of 18F-FDG PET, CT, and MRI in perineural spread of head and neck malignancies.
PubMed 文献 · Eur Radiol · 2017-10-30

这项病例对照探索性研究纳入81例FDG高摄取头颈部恶性肿瘤患者,其中28例有神经周围播散(PNS)为病例组、53例鳞状细胞癌为对照组,从PET、CT和MRI提取影像生物标志物。结果显示PET对PNS检出率100%,PNS与鳞癌患者死亡风险比5.5(95%CI 1.4:20.9)相关,颅神经SUVmax升高与总生存较差相关。

要点

  • 18F-FDG PET/CT可在FDG高摄取头颈部恶性肿瘤中检出神经周围播散。
  • PNS患者多数无症状且为N0、M0,诊断PNS对风险分层至关重要。
  • 鳞癌中PNS与总生存较差相关,多因素分析风险比5.5(95%CI 1.4:20.9)。

核心结论

  • 这项初步研究显示从FDG高摄取头颈部恶性肿瘤的PNS中提取18F-FDG PET生物标志物可行,结果鼓励在进一步前瞻性研究中开发PET/CT或PET/MRI指导的管理策略。

研究设计与样本

  • 病例对照探索性研究(1:2比例),纳入81例FDG高摄取头颈部恶性肿瘤患者,病例组28例经专家共识确认的PNS(含14例鳞状细胞癌),对照组53例鳞状细胞癌;从PNS的18F-FDG PET、CT和MRI提取影像生物标志物,用Cox比例风险回归行单因素和多因素分析。

关键影像表现/征象

  • 18F-FDG PET在病例组对PNS的检出率为100%。
  • PNS代谢较健康组织更具异质性。
  • 多数PNS患者无症状且为N0、M0。

诊断标准与关键数值

  • PNS诊断参考标准为专家共识。
  • 定量影像生物标志物与感觉症状存在无显著关联(p>0.20)。
  • 定量影像生物标志物与运动症状存在无显著关联(p>0.10)。
  • 鳞癌患者中PNS与死亡风险比5.5相关(95%CI 1.4:20.9,多因素分析)。
  • 颅神经SUVmax升高与总生存较差显著相关(单因素分析p=0.001)。

临床应用与阅片要点

  • 在FDG高摄取头颈部恶性肿瘤中,18F-FDG PET/CT可检出PNS。
  • PNS患者多数无症状且为N0、M0,诊断时需关注神经周围播散。
  • 作者鼓励在进一步前瞻性研究中评估PET/CT或PET/MRI指导的管理策略。

局限性

  • 原文自述为初步(pilot)研究。
  • 原文结论鼓励在进一步前瞻性研究中开发PET/CT或PET/MRI指导的管理策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: We assessed whether quantitative imaging biomarkers derived from fluorodeoxyglucose-positron emission tomography (18F-FDG PET) could be extracted from perineural spread (PNS) in head and neck malignancies (HNM) to improve patient risk stratification.

METHODS: A case-control exploratory study (1:2 ratio) enrolled 81 patients with FDG-avid HNM. The case-group comprised 28 patients with documented PNS (reference: expert consensus), including 14 squamous cell carcinomas (SCC). Imaging biomarkers were extracted from the PNS on 18F-FDG PET, CT-scan, and MRI. The control-group enrolled 53 SCCs. The Cox proportional-hazards regression model explored the association with overall survival by univariate and multivariate analyses.

RESULTS: The rate of PNS detection by 18F-FDG PET was 100% in the case-group. Quantitative imaging biomarkers were not associated with the presence of sensory (p>0.20) or motor (p>0.10) symptoms. In SCC patients (case: 14; control: 53), PNS was associated with a hazard ratio of death of 5.5 (95%CI: 1.4:20.9) by multivariate analysis. Increased cranial nerve SUVmax was significantly associated with poorer overall survival by univariate analysis (p=0.001).

CONCLUSIONS: Our pilot study showed the feasibility of extracting 18F-FDG PET biomarkers from PNS in FDG-avid HNM. Our results encourage the development of new PET/CT- or PET/MRI-guided management strategies in further prospective studies.

KEY POINTS: • 18F-FDG PET/CT detects PNS in FDG-avid HNM. • PNS metabolism is more heterogeneous than healthy tissue. • PNS diagnosis is crucial: most patients were asymptomatic, N0 and M0. • PNS diagnosis is associated with poorer overall survival in SCC. • PET/CT- or PET/MRI-guided management strategies should be evaluated.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Dercle L, Hartl D, Rozenblum-Beddok L, et al. Diagnostic and prognostic value of 18F-FDG PET, CT, and MRI in perineural spread of head and neck malignancies. Eur Radiol. 2017. PMID: 29086023. doi:10.1007/s00330-017-5063-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。